Search Results
Timothy S. Pardee, MD, PhD - Hematology and Oncology - Wake Forest Baptist Health
Dr. Pardee Comments on a Phase I Study of the Mitochondrial Metabolism Inhibitor CPI-613 for AML
Dr. Pardee Discusses a Phase I Study of CPI-613 in Advanced Hematologic Malignancies
Dr. Pardee on CPI-613 in Hematologic Malignancies
Dr. Pardee on CPI-613 for Patients With R/R AML
Dr. Pardee on the Mechanism and Utility of CPI-613 for the Hematologic Malignancies
Bayard L. Powell, MD - Hematology and Oncology - Wake Forest Baptist Health
Leslie Renee Ellis, MD - Hematology and Oncology - Wake Forest Baptist Health
Gordon L. Phillips, MD - Hematology and Oncology - Wake Forest Baptist Health
Zanetta S. Lamar, MD - Hematology & Oncology - Wake Forest Baptist Health
Katharine Batt, MD - Hematology and Oncology - Wake Forest Baptist Health
Stefan C. Grant, MD, JD - Hematology & Oncology - Wake Forest Baptist Health
